Hi! 👋 We have a new venture. Please check out Satire Labs, our Medium post, and consider buying our first NFT, "Dumb" SolPunks 😉.
The funniest way to turn your $100 to $1 million. ⛴️ 🚢.
Note: This is a joke. Kinda. We really do think you'll make money 😎🙂

What is ALXN's Shares Outstanding?

  Alexion Pharmaceuticals Inc ( ALXN ) |
1995 - 2021 (27 years)

Shares Outstanding is 
$877.9M (1Y -0.9% )

ALXN Stock Price & Shares Outstanding

Shares Outstanding for ALXN competitors.
CELG GILD REGN VRTX BIIB AGIO RARE IONS QGEN XON
Note: Stonk = Stock. Both words are used interchangeably. 🙂

Historical (All-Time) Stats for Shares Outstanding

chevron_right 2021 $219.1M +11.2x
( +9.7% / year avg)
chevron_left 1995 $17.9M
vertical_align_top Peak $896.0M +49.0x
vertical_align_bottom Bottom $17.9M
arrow_drop_up # Up Years 22 22 of 27
years up.
arrow_drop_down # Down Years 5
Up Years = Positive (0%+) YoY change
Down Years = Zero or Negative (0% or less) YoY change

Key Points (Stonk Price Comparison)

  • ALXN's stock price has rallied +4,601% from $2.31 in 1995 , or +4.02x faster than it's shares outstanding over the same period.
  • If ALXN grows it's stock at the same rate as it's shares outstanding (+9.7%/year) , it's stock price will grow +252% and hit $274.39 over the next 10 years.
  • ALXN's stock price has gone up 0 of the 22 years (0%) it's shares outstanding were also up.
  • ALXN Historical Shares Outstanding Table
    in $ million
    Year Shares Outstanding YoY % Change Stock Price YoY % Change (Stock Price)
    4/1/2021 $219 -75.2% - -
    4/1/2020 $882 -1.3% - -
    4/1/2019 $894 0.4% - -
    4/1/2018 $890 -0.6% - -
    4/1/2017 $896 32.8% - -
    4/1/2016 $674 -18.4% - -
    4/1/2015 $826 4.6% - -
    4/1/2014 $790 1.3% - -
    4/1/2013 $779 3.5% - -
    4/1/2012 $753 3.2% - -
    4/1/2011 $730 2.7% - -
    4/1/2010 $711 5.8% - -
    4/1/2009 $671 11.1% - -
    4/1/2008 $604 5.4% - -
    4/1/2007 $573 41.9% - -
    4/1/2006 $404 -13.2% - -
    4/1/2005 $465 17.6% - -
    4/1/2004 $396 29.8% - -
    4/1/2003 $305 5.0% - -
    4/1/2002 $290 0.5% - -
    4/1/2001 $289 20.7% - -
    4/1/2000 $239 32.8% - -
    4/1/1999 $180 6.1% - -
    4/1/1998 $170 23.5% - -
    4/1/1997 $137 33.9% - -
    4/1/1996 $102 473.5% - -
    4/1/1995 $17 - - -

  • About
    Industry: Biotechnology
    Sector: Healthcare
    Country: US
    IPO Date: 2/1/1996
    Stonk Exchange: NASDAQ
    • Alexion Pharmaceuticals, Inc
    • is a biopharmaceutical company, which focuses on serving patients with devastating and ultra-rare disorders through the development and commercialization of life-transforming therapeutic products.
    • The company is headquartered in Boston, Massachusetts and currently employs 2,656 full-time employees.
    • The firm is focused on the development and commercialization of therapeutic products.
    • The firm's products include Soliris (eculizumab), Strensiq (asfotase alfa) and Kanuma (sebelipase alfa).
    • The firm's clinical development programs include Soliris (eculizumab), cPMP (ALXN1101), SBC-103, ALXN1210 (IV) and ALXN1210 (Subcutaneous).
    • Its Soliris is the therapeutic approved for patients with either paroxysmal nocturnal hemoglobinuria (PNH) or hemolytic uremic syndrome (aHUS).
    • PNH and aHUS result from chronic uncontrolled activation of the complement component of the immune system.
    • Its Strensiq is for the treatment of patients with Hypophosphatasia (HPP).
    • Its product, Kanuma is for the treatment of patients with Lysosomal Acid Lipase Deficiency (LAL-D).
    • The company is a recombinant form of the human LAL enzyme, which is a replacement therapy that is approved for the treatment for patients with LAL-D.

  • Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company’s officers and insiders. Outstanding shares are shown on a company’s balance sheet under the heading “Capital Stock.” The number of outstanding shares is used in calculating key metrics such as a company’s market capitalization, as well as its earnings per share (EPS) and cash flow per share (CFPS). A company's number of outstanding shares is not static and may fluctuate wildly over time.

    For more detailed definitions, please see Investopedia.